The new Liverpool Life Sciences Accelerator building has taken one step closer to completion with its official topping out ceremony.
Situated on Daulby Street the Accelerator will bring together key researchers from LSTM and the Royal Liverpool and Broadgreen University Hospital NHS Trust (RLBUHT) along with a range of SMEs as well as international collaborators in the field of resistance. The 70,000 square foot building will provide state-of-the-art laboratory space and offices.
Those attending the ceremony were welcomed by John Roberts from Integrated Health Partners (IHP), the construction company working on the build. RLBUHT’s Chief Executive Aiden Kehoe described the Accelerator’s journey to today and pointed to the fact that its completion would further cement Liverpool’s position as a hub of Life Sciences. LSTM’s Director, Professor Janet Hemingway, emphasised the importance of further expansion in the field of resistance in all its forms, both antibiotic and other drug and insecticide resistance - fields in which LSTM already excels.
Professor Hemingway said: “There is already a great deal of excitement from industry about the Accelerator, which will see us strengthening our already close research ties with the Royal, encouraging further international links as well as with local SMEs. It is an original offering which will put Liverpool very solidly on the map with its strong knowledge economy.”
The Accelerator is the first development in the creation of a city centre health campus that will be built on the site of the existing Royal Liverpool University Hospital and is due to open in June 2017.